These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10233644)

  • 1. Acute dysarthria induced by low dose methotrexate therapy in a patient with erythrodermic cutaneous T-cell lymphoma: an unusual manifestation of neurotoxicity.
    Aplin CG; Russell-Jones R
    Clin Exp Dermatol; 1999 Jan; 24(1):23-4. PubMed ID: 10233644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients.
    Zackheim HS; Kashani-Sabet M; Hwang ST
    J Am Acad Dermatol; 1996 Apr; 34(4):626-31. PubMed ID: 8601652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-induced necrolysis in tumoral-stage mycosis fungoides: a challenging diagnosis.
    Mna AB; Souissi A; Halouani S; El Euch D; Zahani A; Kchir N; Zaraa I; Mokni M
    Dermatol Online J; 2016 Jan; 22(1):. PubMed ID: 26990481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous cytotoxic T-cell lymphoma].
    Weinstabl A; Megahed M; Rütten A; Rübben A
    Hautarzt; 2011 May; 62(5):329-32. PubMed ID: 21445701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma.
    Delaleu J; Maubec E; Rodrigues F; Lévy A; Szablewski V; Laroche L; Dereure O
    Acta Derm Venereol; 2020 Aug; 100(15):adv00226. PubMed ID: 32516423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate and Pralatrexate.
    Wood GS; Wu J
    Dermatol Clin; 2015 Oct; 33(4):747-55. PubMed ID: 26433846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.
    Maderal AD; Malone JC; Callen JP
    JAMA Dermatol; 2018 Apr; 154(4):490-492. PubMed ID: 29490369
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous panniculitis-like T-cell lymphoma αβ: complete sustained remission with corticosteroids and methotrexate.
    Briki H; Bouaziz JD; Molinier-Frenkel V; Delfau-Larue MH; Ortonne N; Bagot M
    Br J Dermatol; 2010 Nov; 163(5):1136-8. PubMed ID: 20649797
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of cutaneous T-cell lymphoma.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread Skin Necrosis Secondary to Gemcitabine Therapy.
    Zito PM; Gonzalez AM; Fox JD; Cronin M; Mackrides N; Kirsner RS; Nichols AJ
    J Drugs Dermatol; 2018 May; 17(5):582-585. PubMed ID: 29742194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous T-cell lymphoma bullosa: 2 cases].
    Héliot I; Beylot-Barry M; Vergier B; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2003; 130(6-7):639-42. PubMed ID: 13679703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.
    Bruijn MS; Horváth B; van Voorst Vader PC; Willemze R; Vermeer MH
    Br J Dermatol; 2015 Nov; 173(5):1319-22. PubMed ID: 25998985
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T cell lymphoma: update of treatment.
    Zackheim HS
    Dermatology; 1999; 199(2):102-5. PubMed ID: 10559573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma].
    Opherk JP; Lotz J; Galanski M
    Rofo; 2007 Feb; 179(2):175-6. PubMed ID: 17199184
    [No Abstract]   [Full Text] [Related]  

  • 16. Subacute Methotrexate Encephalopathy Mimicking Ischemic Stroke With Dynamic Changes on Magnetic Resonance Imaging.
    Yamanaka K; Okata T; Sambongi Y; Yamanaka I; Tanimoto K; Ago T; Kitazono T; Kitayama J
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):e233-e235. PubMed ID: 30049517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.
    Iwatani K; Fujii N; Deguchi S; Tanimoto M
    Int J Hematol; 2012 Dec; 96(6):683-4. PubMed ID: 23114968
    [No Abstract]   [Full Text] [Related]  

  • 18. A woman who couldn't speak: report of methotrexate neurotoxicity.
    Szawarski P; Chapman CS
    Postgrad Med J; 2005 Mar; 81(953):194-5. PubMed ID: 15749798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does photopheresis reduce the tumor cell burden in erythrodermic cutaneous T-cell lymphoma?
    Zackheim HS
    J Am Acad Dermatol; 1993 Jun; 28(6):1023-4. PubMed ID: 8496451
    [No Abstract]   [Full Text] [Related]  

  • 20. Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma.
    Chung CG; Poligone B
    Dermatol Clin; 2015 Oct; 33(4):787-805. PubMed ID: 26433850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.